Nov 10 (Reuters) - Surgical Science Sweden AB:
* INTERIM REPORT JANUARY-SEPTEMBER 2022: FIRST QUARTER WITH SALES ABOVE SEK 200 MILLION
* Q3 NET SALES AMOUNTED TO SEK 205.1 MILLION (95.3)
* Q3 OPERATING PROFIT AMOUNTED TO SEK 42.7 MILLION (7.6)
* Q3 NET PROFIT AMOUNTED TO SEK 28.5 MILLION (14.4) Source text for Eikon: Further company coverage: (Gdansk Newsroom)